Neurones (NRO) H1 2024 earnings summary

Executive summary

• Achieved 9.1% revenue growth in H1 2024, with 8.2% on a like-for-like basis.

• Operating profit margin held at 9.2% of revenues for H1 2024.

• Net profit after tax reached €29.2 million, representing 7.3% of revenues.

Financial highlights

• H1 2024 revenues were €402.4 million, up from €368.7 million in H1 2023.

• Business operating profit for H1 2024 was €40.5 million (10.1% margin).

• Net cash and cash equivalents stood at €256.9 million, slightly down year-over-year.

Outlook and guidance

• Full-year 2024 revenue forecast maintained at around €800 million.

• Operating profit margin for the year expected to be approximately 9.5%.